Gastric cancer: Prognostic and predictive response therapy factors

C. De Divitiis, V. Canzonieri, R. Cannizzaro, G. Nasti, P. De Paoli, R. Fisichella, M. Berretta

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Despite the recent progress in the development of new therapeutic strategies and in early diagnosis, the prognosis of gastric cancer continues to be poor, with <20% of patients surviving at 5 years. With these perspectives, it becomes of big importance to identify factors helping to predict survival and/or response to treatment, to choose better among the available therapeutic tools.

Original languageEnglish
Title of host publicationPrognostic and Predictive Response Therapy Factors in Cancer Disease (Colorectal, Breast, Liver, Lung, Gastric, Renal and Prostate Cancers)
PublisherNova Science Publishers, Inc.
Pages57-83
Number of pages27
ISBN (Print)9781634635530, 9781634635455
Publication statusPublished - Jan 1 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Gastric cancer: Prognostic and predictive response therapy factors'. Together they form a unique fingerprint.

  • Cite this

    De Divitiis, C., Canzonieri, V., Cannizzaro, R., Nasti, G., De Paoli, P., Fisichella, R., & Berretta, M. (2015). Gastric cancer: Prognostic and predictive response therapy factors. In Prognostic and Predictive Response Therapy Factors in Cancer Disease (Colorectal, Breast, Liver, Lung, Gastric, Renal and Prostate Cancers) (pp. 57-83). Nova Science Publishers, Inc..